Literature DB >> 23906073

Probiotics and clinical effects: is the number what counts?

Elisa Bertazzoni1, Gianfranco Donelli, Tore Midtvedt, Jacques Nicoli, Yolanda Sanz.   

Abstract

Probiotics are defined as 'live microorganisms that when administered in adequate amounts confer health benefits on the host', underlining the need of microbial viability and the requirement of a suitable dose to obtain a health benefit. The dose and the administration regimen are critical issues for probiotics either ingested as foods claiming health benefits or used as drugs in clinics. In fact, regulatory authorities demand to guarantee consumers that a probiotic is effective in the recommended conditions of use and responds to its specific claims. Thus, a proper identification of probiotic strain(s), a definition of the amount of microorganisms surviving by the end of the product shelf-life, and a demonstration of their beneficial effects by appropriate human trials are required. The current knowledge on the effective dose of different probiotic strains used for several disorders is here reviewed.

Entities:  

Mesh:

Year:  2013        PMID: 23906073     DOI: 10.1179/1973947813Y.0000000078

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  13 in total

1.  World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics.

Authors:  Alessandro Fiocchi; Ruby Pawankar; Carlos Cuello-Garcia; Kangmo Ahn; Suleiman Al-Hammadi; Arnav Agarwal; Kirsten Beyer; Wesley Burks; Giorgio W Canonica; Motohiro Ebisawa; Shreyas Gandhi; Rose Kamenwa; Bee Wah Lee; Haiqi Li; Susan Prescott; John J Riva; Lanny Rosenwasser; Hugh Sampson; Michael Spigler; Luigi Terracciano; Andrea Vereda-Ortiz; Susan Waserman; Juan José Yepes-Nuñez; Jan L Brożek; Holger J Schünemann
Journal:  World Allergy Organ J       Date:  2015-01-27       Impact factor: 4.084

Review 2.  Probiotics to counteract biofilm-associated infections: promising and conflicting data.

Authors:  Claudia Vuotto; Francesca Longo; Gianfranco Donelli
Journal:  Int J Oral Sci       Date:  2014-09-26       Impact factor: 6.344

Review 3.  A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis.

Authors:  Lianjun Yang; Liping Wang; Xin Wang; Cory J Xian; Hai Lu
Journal:  Int J Mol Sci       Date:  2016-12-17       Impact factor: 5.923

Review 4.  Probiotics' efficacy in paediatric diseases: which is the evidence? A critical review on behalf of the Italian Society of Pediatrics.

Authors:  Massimo Martinelli; Giuseppe Banderali; Marisa Bobbio; Elisa Civardi; Alberto Chiara; Sofia D'Elios; Andrea Lo Vecchio; Mattia Olivero; Diego Peroni; Claudio Romano; Mauro Stronati; Renato Turra; Irene Viola; Annamaria Staiano; Alberto Villani
Journal:  Ital J Pediatr       Date:  2020-07-25       Impact factor: 2.638

5.  Different Reactions in Each Enterotype Depending on the Intake of Probiotic Yogurt Powder.

Authors:  Songhee Lee; Heesang You; Minho Lee; Doojin Kim; Sunghee Jung; Youngsook Park; Sunghee Hyun
Journal:  Microorganisms       Date:  2021-06-11

Review 6.  Non-alcoholic fatty liver disease, diet and gut microbiota.

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  EXCLI J       Date:  2014-05-07       Impact factor: 4.068

7.  Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season.

Authors:  Chiara Nembrini; Anurag Singh; Carlos Antonio De Castro; Annick Mercenier; Sophie Nutten
Journal:  Clin Transl Allergy       Date:  2015-12-09       Impact factor: 5.871

8.  Supporting a healthy microbiome and patient outcomes with probiotics.

Authors:  Nikhat Contractor; Andrew G Swick; Michael B Montalto; John P Troup
Journal:  Glob Adv Health Med       Date:  2014-05

9.  Experimental support for the effects of a probiotic/digestive enzyme supplement on serum cholesterol concentrations and the intestinal microbiome.

Authors:  Thomas E Ichim; Amit N Patel; Kim A Shafer
Journal:  J Transl Med       Date:  2016-06-22       Impact factor: 5.531

10.  Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis.

Authors:  Larissa Sbaglia Celiberto; Raquel Bedani; Naiara Naiana Dejani; Alexandra Ivo de Medeiros; José Antonio Sampaio Zuanon; Luis Carlos Spolidorio; Maria Angela Tallarico Adorno; Maria Bernadete Amâncio Varesche; Fábio Carrilho Galvão; Sandro Roberto Valentini; Graciela Font de Valdez; Elizeu Antonio Rossi; Daniela Cardoso Umbelino Cavallini
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.